logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Projected cost-effectiveness of primary angioplasty for acute myocardial infarction.

    Article - En anglais

    Objectives

    This study sought to evaluate the cost-effectiveness of primary angioplasty for acute myocardial infarction under varying assumptions about effectiveness, existing facilities and staffing and volume of services.

    Background

    Primary angioplasty for acute myocardial infarction has reduced mortality in some studies, but its actual effectiveness may vary, and most U.S. hospitals do not have cardiac catheterization laboratories.

    Projections of cost-effectiveness in various settings are needed for decisions about adoption.

    Methods

    We created a decision analytic model to compare three policies : primary angioplasty, intravenous thrombolysis and no intervention.

    Probabilities of health outcomes were taken from randomized trials (base case efficacy assumptions) and community-based studies (effectiveness assumptions).

    The base case analysis assumed that a hospital with an existing laboratory with night/weekend staffing coverage admitted 200 patients with a myocardial infarction annually.

    In alternative scenarios, a new laboratory was built, and its capacity for elective procedures was either 1) needed or 2) redundant with existing laboratories.

    Results

    Under base case efficacy assumptions, primary angioplasty resulted in cost savings compared with thrombolysis and had a cost of $12,000/quality-adjusted life-year (QALY) saved compared with no intervention. (...)

    Mots-clés Pascal : Infarctus, Myocarde, Aigu, Dilatation instrumentale, Artère coronaire, Primaire, Analyse coût efficacité, Economie santé, Traitement, Pronostic, Homme, Appareil circulatoire pathologie, Cardiopathie coronaire, Myocarde pathologie, Traitement instrumental

    Mots-clés Pascal anglais : Infarct, Myocardium, Acute, Instrumental dilatation, Coronary artery, Primary, Cost efficiency analysis, Health economy, Treatment, Prognosis, Human, Cardiovascular disease, Coronary heart disease, Myocardial disease, Instrumentation therapy

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0033459

    Code Inist : 002B12A03. Création : 17/04/1998.